FindTrial
Sign In

Genetic Validation study

Replication cohort for refining and validating findings from the Phase I of the Genetic Architecture of Parkinsons disease India study - GAP II study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077381
Enrollment
5000
Registered
2024-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

The Michael J Fox Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with Parkinson’s disease and who give consent to participate in the study

Exclusion criteria

Exclusion criteria: Healthy volunteer with no neurological diseases and who give consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
To thoroughly evaluate the clinical characteristics of the new cohort for validating and replicating the findings from the GAP-India study I.Timepoint: Baseline—

Secondary

MeasureTime frame
Validating & replicating the findings of GAP I study & to perform a collaborative study with Global Parkinson’s Genetics Program (GP2) to assess the role & impact of diverse population-specific variants on the Indian PD population & vice-versa is the goal of our study.Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Asha Kishore

Aster Medcity, Kochi, Kerala

asha.kishore@asterdmhealthcare.com8139890109

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026